A detailed history of Legal & General Group PLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 113,186 shares of TXG stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,186
Previous 113,186 -0.0%
Holding current value
$1.5 Million
Previous $2.56 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.71 - $23.49 $198,605 - $296,960
12,642 Added 12.57%
113,186 $2.56 Million
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $303,167 - $582,486
15,587 Added 18.35%
100,544 $1.96 Million
Q1 2024

May 14, 2024

BUY
$36.08 - $54.3 $21,720 - $32,688
602 Added 0.71%
84,957 $3.19 Million
Q4 2023

Feb 15, 2024

BUY
$34.32 - $57.55 $17,194 - $28,832
501 Added 0.6%
84,355 $4.72 Million
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $76,980 - $118,654
-1,884 Reduced 2.2%
83,854 $3.46 Million
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $33,633 - $38,755
660 Added 0.78%
85,738 $4.79 Million
Q1 2023

May 15, 2023

BUY
$35.33 - $55.79 $236,004 - $372,677
6,680 Added 8.52%
85,078 $4.75 Million
Q4 2022

Feb 14, 2023

SELL
$24.4 - $41.3 $178,876 - $302,770
-7,331 Reduced 8.55%
78,398 $2.86 Million
Q3 2022

Nov 14, 2022

SELL
$28.48 - $52.59 $669,963 - $1.24 Million
-23,524 Reduced 21.53%
85,729 $2.44 Million
Q2 2022

Aug 22, 2022

SELL
$36.95 - $82.41 $7.76 Million - $17.3 Million
-210,088 Reduced 65.79%
109,253 $4.94 Million
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $3.69 Million - $9.66 Million
66,228 Added 26.17%
319,341 $24.3 Million
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $2.67 Million - $3.61 Million
-19,761 Reduced 7.24%
253,113 $37.7 Million
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $1.51 Million - $2 Million
10,384 Added 3.96%
272,874 $39.7 Million
Q2 2021

Aug 12, 2021

BUY
$134.22 - $202.37 $10.6 Million - $16 Million
78,846 Added 42.93%
262,490 $51.4 Million
Q1 2021

May 17, 2021

BUY
$140.25 - $196.86 $1.63 Million - $2.29 Million
11,636 Added 6.76%
183,644 $33.2 Million
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $17.7 Million - $22.9 Million
140,135 Added 439.67%
172,008 $24.4 Million
Q3 2020

Nov 13, 2020

BUY
$87.44 - $125.0 $883,756 - $1.26 Million
10,107 Added 46.43%
31,873 $3.97 Million
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $1.27 Million - $1.94 Million
21,766 New
21,766 $1.94 Million
Q1 2020

May 14, 2020

SELL
$51.57 - $106.62 $360,990 - $746,340
-7,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$46.07 - $79.54 $69,105 - $119,310
1,500 Added 27.27%
7,000 $532,000
Q3 2019

Nov 13, 2019

BUY
$49.99 - $62.0 $274,945 - $341,000
5,500 New
5,500 $278,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.26B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.